Evidence map›Paper›PMID 42516226›Full record

ArticleSurgical case reports2026

A Rapid Progressive Submucosal Tumor Diagnosed as an Idiopathic Pseudoaneurysm in the Subserosal Gastric Wall: A Case Report.

Yuhei Nakano, Susumu Ohwada, Takayuki Aiba, Hideki Matsuyama, Atsushi Arakawa, Kinya Hayakawa

Abstract readCase Reports
In one paragraph

Article in Surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuhei NakanoCenter of Gastroenterology and Oncology, IMS Ota Chuo General Hospital, Ota, Gunma, Japan.
Susumu OhwadaCenter of Gastroenterology and Oncology, IMS Ota Chuo General Hospital, Ota, Gunma, Japan.
Takayuki AibaCenter of Gastroenterology and Oncology, IMS Ota Chuo General Hospital, Ota, Gunma, Japan.
Hideki MatsuyamaCenter of Gastroenterology and Oncology, IMS Ota Chuo General Hospital, Ota, Gunma, Japan.
Atsushi ArakawaEil Inc. Itabashi Chuo Rinshoukensa Kenkyujo, Tokyo, Japan.
Kinya HayakawaEil Inc. Itabashi Chuo Rinshoukensa Kenkyujo, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe classic differential diagnosis of a progressive gastric submucosal tumor (SMT) includes gastrointestinal stromal tumor (GIST), lymphoma, and leiomyoma. But idiopathic pseudoaneurysm is seldom seen. We report the first case of a gastric idiopathic pseudoaneurysm that could not be diagnosed preoperatively. CASE PRESENTATION: An 83-years-old female was referred to our department (Center of Gastroenterology and Oncology, IMS Ota Chuo General Hospital) due to a 39 mm gastric mass accidentally found by CT scan. This mass had rapidly increased in size from 26 to 39 mm in 4 months. She had been seeing cardiology for atrial fibrillation on direct oral anticoagulant drug (DOAC) and chronic heart failure. Diffusion weight image (DWI) of MRI showed a high-intensity area in this mass. We diagnosed rapid progressive SMT and performed distal gastrectomy. The pathological finding was a pseudoaneurysm in the subserosal layer. Since she had no history of trauma or vasculitis, we diagnosed it as an idiopathic pseudoaneurysm. DOAC might contribute to the formation of this pseudoaneurysm. She had no recurrence in 3 years of follow up. To the best of our knowledge, this is the first reported case.

conclusionsGastroenterologists should consider pseudoaneurysm in the differential diagnosis of rapid progressive SMT.

Indexed as

gastrectomygastric wallidiopathic arterial pseudoaneurysmsubmucosal tumor

Identifiers

PMID42516226
PMCPMC13406629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.